Skip to main content
Erschienen in: The Patient - Patient-Centered Outcomes Research 4/2015

01.08.2015 | Original Research Article

Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience

verfasst von: Karin S. Coyne, Brooke M. Currie, William C. Holmes, Joseph A. Crawley

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Many patients with chronic opioid-induced constipation (OIC) seek treatment to relieve their symptoms. A symptom screener may be useful in identifying symptomatic OIC patients.

Aim

The aims of this study were to assess patient understanding of Stool Symptom Screener content and to evaluate how patients described their constipation experience, to better understand the relationship between constipation symptoms and patterns of laxative use.

Methods

Adult OIC patients were recruited through five clinical sites across the USA. Patients were classified as either frequent or non-frequent laxative users. Patients participated in a semi-structured interview to assess their understanding of a Stool Symptom Screener and to discuss their constipation symptoms and laxative use experience. Interview transcripts were reviewed using content analysis. Descriptive statistics were used to characterize the sample.

Results

Sixty-six OIC patients participated: 39 frequent laxative users (mean age 53.3 years) and 27 non-frequent laxative users (mean age 55.5 years). Both patient groups described high levels of symptom burden on the Stool Symptom Screener as well as anecdotally. Both patient groups generally understood the Stool Symptom Screener items and felt the questions were relevant to their symptom experience. Most (95.5 %) reported that they could remember their constipation symptoms “easily” over the previous 2 weeks. No qualitative differences were found between frequent and non-frequent laxative users in how they described their OIC symptom experience.

Conclusion

OIC patients understood this Stool Symptom Screener, and its content was relevant to this highly symptomatic patient sample. Pain and bloating may be considered as additional symptoms for future versions of the screener. An emerging conceptual model of the OIC experience, laxative use, and symptoms is presented.
Literatur
1.
Zurück zum Zitat Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009;5(3):137–44. Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009;5(3):137–44.
2.
Zurück zum Zitat Allan L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322(7295):1154–8.PubMedCentralPubMedCrossRef Allan L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322(7295):1154–8.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61(7):1181–7.PubMedCentralPubMedCrossRef Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61(7):1181–7.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74(8):1347–54.PubMed Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74(8):1347–54.PubMed
5.
Zurück zum Zitat Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Suppl):11S–8S.PubMedCrossRef Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Suppl):11S–8S.PubMedCrossRef
6.
Zurück zum Zitat Überall MA, Müller-Schwefe GHH. Obstiless reports impact of opioid-induced side effects. Section in “International Perspectives on Pain and Palliative Care” by Elon Eisenberg. Pain Palliat Care. 2009;23(1):79–81. Überall MA, Müller-Schwefe GHH. Obstiless reports impact of opioid-induced side effects. Section in “International Perspectives on Pain and Palliative Care” by Elon Eisenberg. Pain Palliat Care. 2009;23(1):79–81.
7.
Zurück zum Zitat Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34(9):870–7.PubMedCrossRef Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34(9):870–7.PubMedCrossRef
8.
Zurück zum Zitat Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain. 2006;10(3):209–17.PubMedCrossRef Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain. 2006;10(3):209–17.PubMedCrossRef
9.
Zurück zum Zitat Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med. 2009;10(1):35–42.PubMedCrossRef Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med. 2009;10(1):35–42.PubMedCrossRef
10.
Zurück zum Zitat Cook S, Bell T, Sweeney C, Fehnel S, Hollis K. Impact on quality of life of constipation-associated GI symptoms related to opioid treatment in chronic pain patients: PAC-QOL results from the opioid survey. J Pain. 2007;9:S71 (Abstract 883). Cook S, Bell T, Sweeney C, Fehnel S, Hollis K. Impact on quality of life of constipation-associated GI symptoms related to opioid treatment in chronic pain patients: PAC-QOL results from the opioid survey. J Pain. 2007;9:S71 (Abstract 883).
11.
Zurück zum Zitat Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005;40(5):540–51.PubMedCrossRef Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005;40(5):540–51.PubMedCrossRef
Metadaten
Titel
Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience
verfasst von
Karin S. Coyne
Brooke M. Currie
William C. Holmes
Joseph A. Crawley
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
The Patient - Patient-Centered Outcomes Research / Ausgabe 4/2015
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-014-0087-7

Weitere Artikel der Ausgabe 4/2015

The Patient - Patient-Centered Outcomes Research 4/2015 Zur Ausgabe